#PRESS: LEO Pharma product approved by European Commission for Chronic Hand Eczema Read more here: leo-pharma.com/media-center #DermatologyBeyondTheSkin

#PRESS: FDA accepts LEO Pharma filing of NDA for Chronic Hand Eczema Read more here: leo-pharma.com/media-center #DermatologyBeyondTheSkin

#PRESS LEO Pharma proudly presents 5 late-breakers and 23 scientific posters at #EADVCongress, demonstrating leadership in medical dermatology.​ Read more here: leo-pharma.com/media-center ​​ #DermatologyBeyondTheSkin

We are excited to be at the #EADVCongres in Amsterdam and look forward to unveiling a wealth of new data including 5 late-breakers and 23 scientific posters to support those living with a range of #SkinConditions. Visit our booth at #B28 and meet our team on the ground.

#PRESS LEO Pharma releases new late-breaker data for #ChronicHandEczema. Read more here: leo-pharma.com/media-center ​ #DermatologyBeyondTheSkin

#PRESS LEO Pharma announces late-breaker at #EADVCongress with new data in #AtopicDermatitis. Read more here: leo-pharma.com/media-center ​ #DermatologyBeyondTheSkin

#PRESS LEO Pharma presents late-breaker highlighting real-world data in #AtopicDermatitis. Read more here: leo-pharma.com/media-center #DermatologyBeyondTheSkin

We were thrilled to attend the #EADVCongress and showcase our extensive data and expertise across several skin conditions. Our onsite team acquired valuable insights that will help further our mission of advancing the standard of care in medical dermatology.

Our financial results from the first nine months of 2024 are out! During this period, we maintained double-digit revenue growth and expanded the global reach of our innovative treatments. Learn more here: leo-pharma.com/media-center #LEOPharma #DermatologyBeyondTheSkin

📣#NEWS: We are partnering with Gilead Sciences to accelerate the development and commercialization of LEO Pharma’s oral #STAT6 program for the potential treatment of patients with inflammatory diseases🤝 👉Read press release leo-pharma.com/media-center/n… #LEOPharma #PressRelease

#PRESS Today, we’re pleased to announce positive phase 3 topline results from our DELTA TEEN trial investigating delgocitinib cream in a new patient population with moderate to severe Chronic Hand Eczma (CHE) #LEOPharma Read more: leo-pharma.com/media-center

#NEWS: We are entering a strategic partnership with DEBRA Research to advance treatments for rare skin diseases🤝 Together we will work on accelerating the development of new medicines for people suffering from Epidermolysis Bullosa. 👉Learn more: lnkd.in/dgTrA_9B

Our #FullYearResults for 2024 are out! 📈Revenue grew 10% (CER) ✅Adjusted EBITDA grew 43% year-over-year 🎯In 2025, revenue growth is projected to be 6-9% (CER) and adjusted EBITDA margin to range from 15-18% 👉Learn more lnkd.in/dUGXtfY9 #LEOPharma #FinancialResults

Our CEO, Christophe Bourdon breaks down some of the highlights from our 2024 #FullYearResults, including how we have strengthened our pipeline and successfully implemented initiatives to further improve our financial performance. 👉 Read full report lnkd.in/dUGXtfY9

2024 delivered strong financial results, building momentum for the year ahead. Looking into 2025, we predict continued growth, substantially improving our financial performance and returning to a positive net result. 👉 Learn more: lnkd.in/dUGXtfY9 #LEOPharma

We are excited to welcome Liisa Hurme and Mark Levick to our Board of Directors! They both bring instrumental experience from a long career within the pharmaceutical industry and have a proven track record of strong results. Learn more: lnkd.in/duyeSTTJ #LEOPharma

We’re going to #AAD2025! What about you? This weekend, the annual American Academy of Dermatology meeting will kick off, bringing together the dermatology industry to share groundbreaking data. 📍Find us at our booth #1009 #LEOPharma #Dermatology AAD AADmember

We have arrived at #AAD2025 With close to 130 LEO Pharma colleagues participating, we’re ready to kick off the annual American Academy of Dermatology meeting. Join us at our booth #1009 to learn more about our latest developments💡 #LEOPharma #Dermatology AADmember

Why is LEO Pharma at #AAD2025? 💡 Over the course of 5 days, we get to engage in insightful discussions, attend groundbreaking presentations, and showcase our own innovative research. 🎬 Hit play to learn more👇 #LEOPharma #AAD #Dermatology #Innovation AADmember

What are your key takeaways from #AAD2025?🧪 As the American Academy of Dermatology annual meeting comes to an end, we asked our leaders who participated in the conference to share their insights💡 #LEOPharma #Dermatology #Innovation AADmember